PTK2 and cancer: Recent studies suggested in cancer cells TAE226 inhibited FAK phosphorylation with an additional effect of inhibiting insulin‐like growth factor‐I receptor (IGF‐IR) 54, whereas little information is available documenting its inhibitory effects on IGF‐IR in podocytes.